title: Screening mammography use and chemotherapy among female stage II colon cancer patients: a retrospective cohort study.
abstract: BACKGROUND
  Although chemotherapy is not a routine recommendation for stage II colon cancer by the U.S. national guidelines, 20-30% of patients have received chemotherapy. This study investigated whether screening mammography use before the cancer diagnosis was associated with chemotherapy use among female elderly patients with stage II colon cancer.
  
  
  METHODS
  Retrospective cohort study on 2910 female stage II colon cancer patients aged 67-79 using the Surveillance, Epidemiology and End Results (SEER)-Medicare data (1996-2002). Screening mammography use and chemotherapy use were identified using Medicare claims data. Multivariate logistic regression and Kaplan-Meier curves were used.
  
  
  RESULTS
  About 25% of female elderly patients received chemotherapy. The chemotherapy rates increased from 22% in 1996-1998 to 26% in 2001-2002. After adjusting for socio-demographic variables, tumor characteristics and Charlson index for comorbidities, the odds of receiving chemotherapy were 28% higher among those who had a screening mammogram before the cancer diagnosis than those who did not (OR: 1.28, 95% CI: 1.07-1.54). Those with a prior mammogram also received chemotherapy earlier than those without. In addition, patients with unfavorable tumor characteristics were more likely to receive chemotherapy. Mammography use before the cancer diagnosis was associated with favorable tumor characteristics.
  
  
  CONCLUSIONS
  Despite the controversy about the chemotherapy use among stage II colon cancer, female elderly patients still received chemotherapy at a high rate. Our findings suggest that patient's health beliefs and health care seeking behavior, together with physician's recommendation, play important roles in the cancer treatment decision.
authors.affiliation: Public Health Program, College of Osteopathic Medicine, Health Professions Division, Nova Southeastern University, Fort Lauderdale, FL, USA. xinhua.yu@nova.edu
authors.forename: Xinhua
authors.initials: X
authors.lastname: Yu
authors.forename: Alexander M
authors.initials: AM
authors.lastname: McBean
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001943:Breast Neoplasms / Q000000981:diagnostic imaging; D003110:Colonic Neoplasms / Q000188:drug therapy* / Q000473:pathology*; D005260:Female; D006801:Humans; D016015:Logistic Models; D008327:Mammography / Q000706:statistics & numerical data*; D008403:Mass Screening / Q000706:statistics & numerical data*; D009367:Neoplasm Staging; D010342:Patient Acceptance of Health Care; D012189:Retrospective Studies; D012959:Socioeconomic Factors
chemical_list: D000970:Antineoplastic Agents
references.citation: Int J Canc Prev. 2005 May;2(3):169-179
references.pmid: 19122776
references.citation: N Engl J Med. 2001 Oct 11;345(15):1091-7
references.pmid: 11596588
references.citation: J Clin Epidemiol. 1992 Jun;45(6):613-9
references.pmid: 1607900
references.citation: Med Care. 2002 Aug;40(8 Suppl):IV-3-18
references.pmid: 12187163
references.citation: J Behav Med. 1994 Aug;17(4):391-406
references.pmid: 7966260
references.citation: Am J Med. 2005 Oct;118(10):1078-86
references.pmid: 16194635
references.citation: Acad Radiol. 2005 Apr;12(4):451-8
references.pmid: 15831418
references.citation: Lancet. 2007 Dec 15;370(9604):2020-9
references.pmid: 18083404
references.citation: J Clin Oncol. 2006 May 20;24(15):2368-75
references.pmid: 16618946
references.citation: Am J Gastroenterol. 2003 Aug;98(8):1875-80
references.pmid: 12907347
references.citation: J Natl Cancer Inst. 2001 Jun 6;93(11):850-7
references.pmid: 11390534
references.citation: Med Care. 2006 Oct;44(10):921-8
references.pmid: 17001263
references.citation: JAMA. 2007 Nov 14;298(18):2149-54
references.pmid: 18000198
references.citation: J Chronic Dis. 1987;40(5):373-83
references.pmid: 3558716
references.citation: Cancer. 2006 Dec 1;107(11):2581-8
references.pmid: 17078055
references.citation: Womens Health Issues. 2005 Nov-Dec;15(6):249-57
references.pmid: 16325138
references.citation: J Clin Oncol. 2002 Oct 1;20(19):3999-4005
references.pmid: 12351597
references.citation: J Natl Cancer Inst. 2006 May 3;98(9):610-9
references.pmid: 16670386
references.citation: J Clin Oncol. 2004 Aug 15;22(16):3408-19
references.pmid: 15199089
references.citation: J Cancer Surviv. 2007 Dec;1(4):275-82
references.pmid: 18648962
references.citation: Int J Colorectal Dis. 2007 Aug;22(8):887-95
references.pmid: 17235506
references.citation: Am J Obstet Gynecol. 2008 Jan;198(1):86.e1-8
references.pmid: 18166316
references.citation: Med Care. 2002 Aug;40(8 Suppl):IV-55-61
references.pmid: 12187169